Clinical Trials Browser

Phase 4 × Neutropenia × pegylated granulocyte colony-stimulating factor × Clear all

NCT04009941 2020-10-28

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Phase 4 Completed

Breast Neoplasms, Neutropenia